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Abstract
Background: There is a lack of information on the clinical characteristics of multidrug-resistant (MDR) tuberculosis
(TB) and extensively drug-resistant (XDR) TB in the Jiangxi Province of China; furthermore, data have not been
reported on the utility of mycobacterial interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR)
analyses in genotyping Mycobacterium tuberculosis strains isolated from this region. The aim of this study was to
analyse the clinical features of patients with MDR and XDR TB from Jiangxi Province and to evaluate the
discriminatory power of the 15-loci MIRU-VNTR method.
Methods: A retrospective study was conducted on patients diagnosed with MDR and XDR TB at the Jiangxi Chest
Hospital from July 2010 to June 2011. The RD105 deletion-targeted multiplex PCR (DTM-PCR) and the 15-loci MIRU-
VNTR method were used to determine the genetic background of the identified MDR and XDR M. tuberculosis
clinical isolates.
Results: Of 804M. tuberculosis clinical isolates, 159 (159/804, 19.8%) of the isolates were identified as MDR with first-
line drug susceptibility testing. Of the 123 available MDR isolates, 13 (13/123, 10.6%) were XDR. The RD105 deletion-
targeted multiplex PCR method identified 85 (85/110, 77.3%) MDR and 12 (12/13, 92.3%) XDR isolates as the Beijing
genotype. MIRU-VNTR cluster analysis demonstrated that 101 MDR and 13 XDR strains had unique genotype
patterns; the remaining 9 MDR strains were in 4 clusters, namely 1 cluster with 3 strains and 3 clusters with 2
strains, resulting in a low clustering rate (4.06%). The Hunter-Gaston discriminatory index (HGDI) of the 15-loci
MIRU-VNTR method was as high as 0.992. In addition, clinical surveys showed that 87 (87/110, 79.1%) MDR TB
patients and 10 (10/13, 76.9%) XDR TB patients had been previously treated. Diabetes mellitus was the most
common comorbidity in both MDR TB (16/110, 14.5%) and XDR TB (2/13, 15.4%) patients.
Conclusions: Based on our preliminary data, the MDR and XDR M. tuberculosis clinical isolates identified at the
Jiangxi Chest Hospital were genetically diverse and clustered at a low frequency. The 15-loci MIRU-VNTR method
showed high discriminatory power and may be used as a first-line genotyping tool in investigating the molecular
epidemiology of M. tuberculosis in Jiangxi, China. Decisive measures are urgently needed to effectively prevent and
manage MDR and XDR tuberculosis in this province.
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Background
The emergence of multidrug-resistant (MDR) tuber-
culosis (TB) and extensively drug-resistant (XDR) TB
strains poses formidable challenges to the control of TB
because infection with either MDR or XDR Mycobacter-
ium tuberculosis strains can result in more serious
disease, prolonged infectiousness, and a poor prognosis
[1]. In 2010, approximately 8.8 million incident cases of
TB were reported globally, and there were an estimated
650,000 prevalent cases of MDR TB [2]. According to
the World Health Organization, 84 countries had reported
at least 1 case of XDR TB by October 2012. China is one
of the 27 high MDR and XDR TB burden countries, where
the prevalence of MDR TB was found to be 5.3% and
27.4% in new and previously treated cases respectively,
according to a recent systematic review and meta-
analysis [3].
Determination of the clinical characteristics and mo-
lecular epidemiology of MDR and XDR TB is helpful in
their diagnosis and containment. MIRU-VNTR (mycobac-
terial interspersed repetitive-unit-variable-number tandem-
repeat) is a simpler and faster genotyping method with
discriminatory power equivalent to that of IS6110 RFLP,
and it has been widely used for studying the transmission
dynamics of M. tuberculosis [4]. Currently, MIRU-VNTR
genotyping is usually performed with one of three panels
(12, 15, or 24 loci) [5,6]. Previous studies showed that the
discriminatory power of MIRU-VNTR genotyping varies in
different geographical areas [5,7-9]. Thus, it is necessary to
choose the optimal panel or loci to improve the discrimin-
atory power for genotyping MTB strains isolated from a
given region.
Jiangxi Province is a resource-limited and high TB
burden area in the southeast part of China; here, the
prevalence of bacteriologically positive pulmonary TB
was estimated at 203.6 cases per 100,000 inhabitants in
2000 [10]. Recently, we reported the molecular muta-
tions and genetic lineage of MDR and XDR strains iso-
lated from this province [10]. However, there remains
little information on the clinical characteristics of MDR
and XDR TB in Jiangxi Province. No study has assessed
the utility of MIRU-VNTR analyses in genotyping M.
tuberculosis strains isolated from this region. Therefore,
we conducted a retrospective study to investigate the
clinical features of patients diagnosed with MDR and
XDR TB at the Jiangxi Chest Hospital and determined
the genetic diversity of the identified MDR and XDR M.
tuberculosis clinical isolates using the RD105 deletion-
targeted multiplex PCR (DTM-PCR) and the 15-loci
MIRU-VNTR method [11]. The 15-locus panel is pro-
posed as the standard for routine epidemiological discrim-
ination of M. tuberculosis isolates [6], the discriminatory
power of the 15-loci MIRU-VNTR method used in this
study was further evaluated.
Methods
M. tuberculosis isolates
This survey was conducted between July 2010 and June
2011 at the Jiangxi Chest Hospital located in the capital
of Jiangxi Province and serving as the sole specialised
tertiary care TB hospital in the province. A total of 804
M. tuberculosis clinical isolates were obtained, each from
a unique patient with pulmonary TB living in Jiangxi
Province. The M. tuberculosis strain H37Rv (ATCC27294)
was used as a reference. All isolates were cultured in
Löwenstein-Jensen medium. Species identification of M.
tuberculosis was performed using p-nitrobenzoic acid and
thiophene carboxylic acid hydrazide resistance tests [12].
This study was approved by the Institutional Review
Board of the Third Affiliated Hospital of Sun Yat-Sen Uni-
versity and the Jiangxi Chest Hospital.
Drug susceptibility testing
For all 804M. tuberculosis isolates collected, first-line drug
susceptibility testing (DST) was routinely performed on
Löwenstein-Jensen medium using the 1% proportion
method. To further identify XDR isolates, DST for four
representative second-line drugs (ofloxacin, kanamycin,
amikacin, and capreomycin) was performed for all available
MDR strains identified in the study. This testing was
performed in accordance with the WHO Guidelines [13]
using the following drug concentrations: isoniazid (0.2 μg/
ml), rifampin (40.0 μg/ml), streptomycin (4.0 μg/ml), eth-
ambutol (2.0 μg/ml), ofloxacin (2. 0 μg/ml), kanamycin
(30.0 μg/ml), amikacin (40.0 μg/ml), and capreomycin
(40.0 μg/ml). Quality control was routinely performed dur-
ing DST using the reference strain H37Rv (ATCC27294).
Data collection and definitions
During the survey period, all MDR and XDR TB patients
(n = 159) identified by DST at the Jiangxi Chest Hospital
were enrolled in the study. The following clinical infor-
mation was obtained from the study patients’ medical
records: gender, age, complication, TB treatment history,
presence of cavities on chest radiograph, and human im-
munodeficiency virus (HIV) status.
MDR TB was defined as a strain showing resistance to
at least isoniazid and rifampicin, while XDR TB was de-
fined as MDR TB with additional resistance to ofloxacin
and at least to one of the following three second-line
injectable drugs: kanamycin, amikacin, or capreomycin
[14,15]. New or previously treated TB cases were defined
as previously described [16].
Genotyping procedures
Genomic DNA was extracted from M. tuberculosis isolates
using the cetyltrimethylammonium bromide (CTAB)
method as previously described [17]. Identification of the
Beijing family was performed for all (n = 123) available
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MDR and XDR strains collected in this study using the
RD105 deletion-targeted multiplex PCR (DTM-PCR)
method [18]. All (n = 123) available MDR and XDR strains
were genotyped using the 15-loci MIRU-VNTR technique
as described by Supply et al. [6]. PCR products were
analysed by electrophoresis on 1.5% agarose gels, and
the size analysis of PCR fragments was performed using
the Gel Image Analysis System (Tanon2500, Shanghai,
China). The corresponding number of repetitions of
various MIRU-VNTR loci of each strain was determined
by comparison with the reference table from the MIRU-
VNTR typing manual provided by Philip Supply (http://
www.miru-vntrplus.org/MIRU/files/MIRU-VNTRtyping
manualv6.pdf ). To ensure the accuracy of the DTM-PCR
and MIRU-VNTR methods, the H37Rv M. tuberculosis
strain and sterile water were used in each experiment as
positive and negative controls, respectively.
Cluster analysis
MIRU-VNTR genotyping data were transformed into a
distance matrix on the web site MIRU-VNTRplus (http://
www.miru-vntrplus.org) using the default setting and
treated as categorical variables. Phylogenetic analysis of
the distance data was conducted by the neighbour-joining
(NJ) algorithm using MEGA version 5.05 [19]. A mini-
mum spanning tree was constructed through the web site
MIRU-VNTRplus (http://www.miru-vntrplus.org) based
on the 15-loci MIRU-VNTR genotyping data [20]. The
Hunter-Gaston discriminatory index (HGDI) of MIRU-
VNTR types was calculated as described previously [21]
and categorised according to the criteria proposed by Sola
et al. [22]. Isolates with identical MIRU-VNTR genotypes
were defined as belonging to the same cluster. The clus-
tering rate was defined as (nc–C)/N, where nc is the total
number of clustered cases, C is the number of clusters,
and N is the total number of cases in the sample [7].
Statistical analysis
Categorical data analysis was performed with SPSS ver-
sion 16.0 (SPSS Inc., Chicago, Illinois, USA) by using χ2
or Fisher’s exact tests when the theoretical frequency
was less than five. A p value < 0.05 was considered to be
statistically significant.
Results
Identification of MDR and XDR M. tuberculosis strains
During the study period, there were 159 (19.8%, 159/
804) MDR strains identified among the 804M. tubercu-
losis strains using first-line DST at the Jiangxi Chest
Hospital. To determine the number and percentage of
XDR strains, we performed DST using four second-line
drugs on all available MDR strains in this study. How-
ever, 36 of the 159 MDR strains were contaminated,
missing, or could not be recovered from storage. The
remaining 123 MDR strains were tested for susceptibility
804 M. tuberculosis strains based onthe 
first-line drug susceptibility tests
TB cases without MDR:
n=645
MDR TB cases:
n=159 (19.8%)
TB cases whose strains were not 
available: n=36
123 availableMDR strains based on the  
second-line drug susceptibility tests 
TB cases without XDR:
n=110
XDR TB cases:
n=13 (10.6%)
Figure 1 Study profile of MDR and XDR TB patients at Jiangxi Chest Hospital, July 2010-June 2011. TB = tuberculosis; MDR =multidrug-
resistant; XDR = extensively drug-resistant.
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to second-line drugs; of these, 13 were identified as XDR
strains (10.6%, 13/123) (Figure 1).
Clinical characteristics of MDR and XDR TB patients
We compared patient characteristics associated with
MDR (n = 110) and XDR (n = 13) TB (Table 1). Eighty-
six (86/110, 78.2%) of 110 MDR TB patients were 20–
59 years old, and 7 (7/13, 53.8%) of 13 XDR TB cases
were more likely to occur in individuals aged 40–59 years.
Eighty-seven (87/110, 79.1%) MDR TB patients and 10
(10/13, 76.9%) XDR TB patients were previously treated
cases (defined as patients who had received one or more
months of anti-TB drugs in the past [23]). Of 123 patients,
HIV status was available for 94 individuals. Among these
individuals, none tested positive. It is noteworthy that dia-
betes mellitus was the most common comorbidity in both
MDR (16/110, 14.5%) and XDR (2/13, 15.4%) TB patients.
In addition, XDR TB (11/13, 84.6%) cases were more likely
to present with a cavity on chest radiograph compared
with MDR TB (64/110, 58.2%) cases. However, there was
no significant difference in chest radiograph results be-
tween the groups.
Genotyping of MDR and XDR M. tuberculosis strains
We genotyped 1 isolate each from the 110 MDR TB and
13 XDR TB patients. Among them, the genetic lineage
of 59 MDR strains and 10 XDR strains had been reported
in a previous study [10]. Initially, the DTM-PCR method
identified 85 (85/110, 77.3%) MDR and 12 (12/13, 92.3%)
XDR isolates as Beijing genotype (Table 1). Furthermore,
26 non-Beijing family strains were assigned to various lin-
eages using a similarity search on the MIRU-VNTRplus
website. The distribution of these 26 strains within the
various lineages is shown in Figure 2. The most prevalent
genotype among these strains was the S family (7/26,
26.9%), followed by NEW-1(3/26, 11.5%), Cameroon (2/
26, 7.7%), NEW-2 (1/26, 3.8%), and URAL (1/26, 3.8%).
The remaining 12 strains (12/26, 46.2%) could not be
assigned to a single lineage by the 15-loci MIRU-VNTR
method. The minimum spanning tree analysis indicated
that the 123 isolates were divided into 4 clonal com-
plexes (CC1–CC4) and 22 singletons (Figure 3). CC1 in-
cluded 95 strains, which mostly belonged to the Beijing
family. CC2, CC3, and CC4 each contained two non-
Beijing strains (Figure 3).
A dendrogram based on the 15-loci MIRU-VNTR
method was constructed using a neighbour-joining algo-
rithm and is shown in Additional file 1. Altogether,
MIRU-VNTR cluster analysis showed that the 123 strains
were classified into 118 genotypes. A total of 114 strains
had unique patterns, while the remaining 9 strains were
grouped into 4 clusters: 1 cluster with 3 strains and 3
clusters with 2 strains, resulting in a low clustering rate
(4.06%). None of the XDR strains were in a genotype
cluster.
The allelic diversity (h) of the 123M. tuberculosis
strains at each MIRU-VNTR locus varied significantly,
as summarised in Table 2. Among the 15 loci, the allelic
diversity for 7 loci (Mtub04, Mtub21, MIRU04, MIRU26,
MIRU31, QUB-11b, and QUB-26) exceeded 0.6, indicat-
ing that they are highly discriminatory. Another seven
loci (MIRU10, MIRU16, MIRU40, ETR-A, QUB-4156,
Mtub30, and Mtub39) showed moderate discrimination
(0.3 ≤ h ≤ 0.6), and the final locus, ETR-C, was less
polymorphic (h < 0.3) [22]. The highest diversity among
the 123 strains was observed at MIRU26 (h = 0.83); the
lowest diversity was observed at ETR-C (h = 0.02). The
HGDI of the 15-loci MIRU-VNTR method was as high
Table 1 Characteristics of MDR and XDR TB patients from
Jiangxi Province, China, July 2010-June 2011
Variable MDR TB,
n = 110 (%)
XDR TB,
n = 13 (%)
χ2 p value
Age (years) 1.61 0.81
10–19 3 (2.7) 0 (0)
20–39 40 (36.4) 4 (30.8)
40–59 46 (41.8) 7 (53.8)
60–79 19 (17.3) 2 (15.4)
≥80 2 (1.8) 0 (0)
Sex 0.49 0.53
Male 78 (70.9) 8 (61.5)
Female 32 (29.1) 5 (38.5)
Cavity on chest radiograph 3.41 0.07
Yes 64 (58.2) 11 (84.6)
No 46 (41.8) 2 (15.4)
Treatment 0.03 1.00
New cases 23 (20.9) 3 (23.1)
Previously treated cases 87 (79.1) 10 (76.9)
HIV status 1.79 0.18
Positive 0 (0) 0 (0)
Negative 86 (78.2) 8 (61.5)
Unknown 24 (21.8) 5 (38.5)
Comorbidity 0.00 1.00
Diabetes mellitus 16 (14.5) 2 (15.4)
COPD 8 (7.3) 2 (15.4)
Hepatitis 6 (5.5) 1(0.9)
Malignancy 3 (2.7) 0 (0)
Gout 1 (0.9) 0 (0)
Ventricular septal defect 0 (0) 1 (7.7)
Parkinson's disease 0 (0) 1 (7.7)
Beijing family genotype 0.37 0.73
Yes 85 (77.3) 12 (92.3)
No 25 (22.7) 1 (7.7)
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as 0.992. Three representative amplified bands at locus
Mtub21, MIRU26, and ETR-C for some clinical strains
tested are shown in Figure 4. The clinical strains demon-
strated diverse electrophoretic bands at both loci Mtub21
and MIRU26, while they showed almost the same electro-
phoretic band at locus ETR-C.
Discussion and conclusions
Based on a hospital-based survey of drug-resistant cases,
the findings that the rate of MDR TB was 19.8% and that
10.6% of MDR cases were XDR are similar to a report
from the Chinese PLA 309 Hospital [24]. Although data
from a specialised TB hospital is not representative of
Jiangxi Province as a whole, our data suggest that the
emergence of MDR and XDR TB may be a severe prob-
lem and that TB control is a major concern for the
region. The strict Directly Observed Treatment Short
Course (DOTS) is the core principle of the Stop TB
Strategy and is considered to reduce the incidence of ac-
quired drug-resistant TB [25]. The provincial project of
DOTS has been implemented in the Jiangxi region since
January 1, 2005. However, most of the MDR (79.1%) and
XDR (76.9%) TB patients from the Jiangxi region were
previously treated cases, in addition to the high rate of
MDR and XDR TB cases in this study. These facts sug-
gested that the DOTS may not be performing as well in
Jiangxi Province compared with some areas of Shandong
Province, which could be due to a lack of sufficient
professional personnel, insufficient financial support, or pa-
tients’ poor adherence to the DOTS regimen [26]. Thus, it
is necessary to adopt urgent measures for preventing and
managing MDR and XDR TB effectively in this province.
In the present study, we found that most MDR and
XDR TB patients were between 20 and 59 years old, with
a peak frequency between 40 and 59 years old, which was
in agreement with results from two recent investigations
in Japan and China [27]. However, it is unclear why MDR
and XDR TB were more likely to occur in individuals aged
20–59 years. This result could be partly explained by the
fact that the majority of MDR and XDR TB patients
undertook self-administration of treatment before the pro-
vincial DOTS project was implemented in the Jiangxi
region in 2005. Inadequate monitoring and inappropriate
treatment regimens could result in more drug-resistant
cases than those occurring after the introduction of
DOTS. Another possible explanation is poorer treatment
adherence due to their heavy workloads and significant
mental pressure relative to younger or older patients [28].
It is well known that diabetes mellitus is an important
risk factor for TB [29]. Nevertheless, the relationship be-
tween diabetes mellitus and MDR TB is still controver-
sial. Some studies have shown that diabetic patients are
more likely to develop MDR TB compared with those
without diabetes [30-32], while other studies found no
significantly increased risk [33-35]. This discrepancy
could be the result of these studies being hospital-based
Figure 2 Lineage distribution of 26 non-Beijing family isolates identified by a similarity search on the MIRU-VNTRplus website.
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with a small sample size in different settings. A national
study indicates that the age-standardised prevalence of
total diabetes was 9.7% among Chinese inhabitants and
that diabetes has become a major public health problem
in China [36]. Diabetes mellitus is becoming the pre-
dominant force driving the spread of TB [29,31]. Thus,
it is important to clarify the relationship between dia-
betes mellitus and drug resistance. To achieve this goal,
population-based studies with large sample sizes, espe-
cially in high TB-burden countries, are urgently needed.
As anticipated, population structure analysis of MDR
and XDR M. tuberculosis strains identified in this study
showed that the Beijing family (97/123, 78.9%) was the
predominant genotype, which is in accordance with
reports from neighbouring provinces such as Anhui
(85.3%), Zhejiang (70%), and Shanghai (77.1%) [7,28]. In
addition, the S family (originally prevalent in Europe and
America [37]) was the predominant sublineage (7/26,
26.9%) of non-Beijing family strains in this study. These
results indicated that strains of the S family may have
spread throughout Jiangxi Province. Further studies are
required to validate this hypothesis, using more patterns
of drug-resistant and drug-sensitive clinical strains.
The present study demonstrated that the discrimin-
atory power of the 15-loci MIRU-VNTR method was
very high, although the majority of the MDR and XDR
strains from Jiangxi Province belonged to the Beijing
family. Furthermore, 14 of the 15 loci investigated in this
study (excluding ETR-C) showed relatively moderate or
high discrimination (h > 0.3) [22]. Therefore, it can be
expected that the 15-loci MIRU-VNTR technique may
be a highly discriminatory tool for differentiating be-
tween clinical strains isolated from the region. However,
the ETR-C locus showed very low diversity (h = 0.02) in
this study, which is in agreement with several studies
from other areas of China [4,7,38,39]. In contrast, ETR-
C showed high discriminatory power in a study from
Spain (h = 0.63) [5] and in another study from France
(h = 0.71) [6]. These results indicate that ETR-C is not
suitable for the genotyping of the M. tuberculosis strains
circulating in China.
In the present study, a detailed genetic analysis of
MDR and XDR M. tuberculosis isolates was performed
using the MIRU-VNTR method, resulting in the identifi-
cation of 123 resistant strains among patients in the
Jiangxi Province of China. The 123 strains showed great
Figure 3 Minimum Spanning Tree. This tree was generated with 15 MIRU-VNTR loci of the 123 strains from Jiangxi Province, China, using the
MIRU-VNTRplus database (http://www.miru-vntrplus.org). CC1, CC2, CC3, and CC4 represent four major clonal complexes. The maximum locus
difference within a clonal complex is five. The red circle denotes the Beijing family strain, while the blue circle denotes the non-Beijing
family strain.
Yuan et al. BMC Infectious Diseases 2013, 13:315 Page 6 of 9
http://www.biomedcentral.com/1471-2334/13/315
genetic diversity and a low clustering percentage. In
addition, most of these MDR and XDR TB patients identi-
fied at the Jiangxi Chest Hospital were previously treated
cases. These results indicated that the prevalence of most
MDR and XDR TB in the Jiangxi region may not be
caused by clonal dissemination. Meanwhile, we noted that
more than one-fifth of the MDR and XDR TB patients
were new cases, which may have been caused by the active
transmission of drug-resistant TB. Drug-sensitive strains
are easily eliminated and their transmission is rare after
treatment, whereas MDR TB is less successfully treated
and spreads preferentially [40]. Therefore, primary drug
resistance may also play an important role in the develop-
ment of MDR and XDR TB in this region [25].
There were some limitations of the present study.
First, our results likely overestimated the percentage of
drug resistance compared with population-based studies
because a greater proportion of seriously ill TB cases
may be included in a hospital-based study. In contrast,
the clustering rate of drug-resistant TB was likely
underestimated in our one-year molecular epidemiologic
survey because the clustering proportion depends on the
completeness of sampling, where increasing sampling
fractions will identify more clustering [39,41]. Second,
twelve non-Beijing family isolates were categorised as
“unknown” in the present study using a similarity search
on the MIRU-VNTRplus website. This result could be
due to the recent creation of the MIRU-VNTRplus
database; the database was first published in 2008 and
Table 2 Allelic diversity of the 15 MIRU-VNTR loci in the
110 MDR and 13 XDR M. tuberculosis strains from Jiangxi,
China
VNTR
locus
VNTR
alias
Range of
repeats
Allelic diversity (h) for
Beijing
isolates
(n = 97)
Non-Beijing
isolates
(n = 26)
All isolates
(n = 123)
424 Mtub04 1-5,7 0.49 0.74 0.61
577 ETR-C 2–4 0.01 0.04 0.02
580 MIRU04 2–8 0.75 0.67 0.75
802 MIRU40 1–4 0.33 0.62 0.43
960 MIRU10 1–6 0.34 0.65 0.49
1644 MIRU16 1–5 0.43 0.57 0.48
1955 Mtub21 0–9 0.77 0.79 0.82
2163b QUB-11b 1–8 0.70 0.79 0.75
2165 ETR-A 1–4 0.23 0.51 0.40
2401 Mtub30 1–4 0.29 0.55 0.49
2996 MIRU26 1–10 0.79 0.79 0.83
3192 MIRU31 1–8 0.71 0.68 0.76
3690 Mtub39 1–6 0.13 0.63 0.34
4052 QUB-26 1–4,6-12 0.70 0.84 0.75
4156 QUB-4156 0-6 0.53 0.55 0.55
1   2  3   4  5  6   7  M1 1   2  3  M2 4  5   6   7  8  9  M1
(a) MIRU26 (b) ETR-C
M2 1   2    3   4    5   6   7   8   9   10   11  12  13   14  M1
(c) Mtub21
Figure 4 Length polymorphisms of three loci{(a) MIRU26, (b) ETR-C, and (c) Mtub21} for some of the tested clinical isolates from
Jiangxi Province, China (M1: 100 bp DNA Marker, M2: 50 bp DNA Marker).
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currently has a limited number of reference strains avail-
able for comparison [8].
Despite these limitations, we believe that the clinical
and epidemiological information presented here is of
particular value for the prevention and management of
drug-resistant TB in the Jiangxi area. Based on our pre-
liminary data, the MDR and XDR M. tuberculosis clin-
ical strains identified at the Jiangxi Chest Hospital were
genetically diverse and clustered with low frequency.
The 15-loci MIRU-VNTR method showed a high HGDI
and may be used as a first-line genotyping tool in com-
bination with DTM-PCR for molecular epidemiological
studies of M. tuberculosis in Jiangxi, China. Decisive
measures are urgently needed to effectively prevent and
manage MDR and XDR tuberculosis in this province.
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